Skip to main content
. 2016 Oct 19;5(12):3386–3393. doi: 10.1002/cam4.919

Table 4.

Thyroid and hematologic status in sunitinib‐treated patients (available data n = 42)

Developed hypothyroidism (n = 19) Remained euthyroid (n = 23)
Developed macrocytosis n = 26 13 (31%) 13 (31%)
Remained normocytic n = 16 6 (14%) 10 (24%)
Average peak MCV 103.8 99.67